Originalsprog | Engelsk |
---|---|
Tidsskrift | Haematologica |
Vol/bind | 105 |
Udgave nummer | 12 |
Sider (fra-til) | 2879-2882 |
Antal sider | 4 |
ISSN | 0390-6078 |
DOI | |
Status | Udgivet - dec. 2020 |
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial
Sonja Zweegman, Claudia A M Stege, Einar Haukas, Fredrik H Schjesvold, Mark-David Levin, Anders Waage, Rineke B L Leys, Saskia K Klein, Damian Szatkowski, Per Axelsson, Trung Hieu Do, Dorota Knut-Bojanowska, Ellen van der Spek, Asta Svirskaite, Anja Klostergaard, Morten Salomo, Celine Blimark, Paula F Ypma, Ulf-Henrik Mellqvist, Pino J Poddighe
Publikation: Bidrag til tidsskrift › Letter › peer review
23
Citationer
(Scopus)